Back to search results

A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

GIST

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Rabia Rehman) · rabia.rehman@med.usc.edu · 323-865-3000
    Contact: Principal Investigator (Syma Iqbal, MD)

  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles, California, United States

    Contact: Study coordinator (Jacqueline Banuelos) · jbanuelosmurillo@mednet.ucla.edu · 310-869-7014
    Contact: Principal Investigator (Arun Singh, MD)

  • Sylvester Comprehensive Cancer Center, Miami, Florida, United States

    Contact: Study coordinator (Nailet Bestard) · nxr518@med.miami.edu · 305-243-8173
    Contact: Principal Investigator (Jonathan C Trent, MD, PhD)

  • University of Massachusetts Worcester, Worcester, Massachusetts, United States

    Contact: Study coordinator (Syliva Rollins) · Sylvia.Rollins@umassmed.edu · 7744554454

  • START Midwest, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Julie Burns) · julie.burns@startmidwest.com · 616-954-5559
    Contact: Principal Investigator (Sreenivasa Chandana, M.D., Ph.D.)

  • Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States

    Contact: Study coordinator (Tori Tuma) · tuma@wustl.edu · 314-747-9488
    Contact: Principal Investigator (Mia Weiss, MD)

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York, New York, United States

    Contact: Study coordinator (Pragya Khadka) · khadkap1@mskcc.org
    Contact: Study coordinator (Melessa Hardayal) · hardayam@mskcc.org
    Contact: Principal Investigator (Ping Chi, MD, PhD)

  • Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Cancer Answer) · canceranswer@ccf.org · 216-444-7923

  • Oregon Health & Science University, Portland, Oregon, United States

    Contact: Study coordinator (Knight Cancer Institute Clinical Trials) · trials@ohsu.edu · 503-494-1080

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Refiola Memushi) · Refiola.Memushi@fccc.edu · (215)-728-3564
    Contact: Principal Investigator (Margaret von Mehren, MD)

  • Virginia Cancer Specialist, PC, Fairfax, Virginia, United States

    Contact: Study coordinator (Anthony Jones) · anthony.jones@usoncology.com · 571-512-3202
    Contact: Principal Investigator (Chao Yin, MD)

  • Aarhus University Hospital, Aarhus, Denmark

    Study coordinator · ninnpede@rm.dk · +4591167534
    Contact: Principal Investigator (Ninna Aggerholm Pedersen, MD)

  • Centre Oscar Lambret, Lille, France

    Study coordinator · l-lebellec@o-lambret.fr · +1 (123) 456-7891
    Contact: Principal Investigator (Loic Lebellec, MD)

  • Institut Curie, Service d'Oncologie Médicale, Paris, France

    Study coordinator · clement.bonnet@curie.fr · 33142494217
    Contact: Principal Investigator (Clement Bonnet, MD)

  • Hôpital Européen Georges Pompidou, Paris, France

    Study coordinator · +33156092802
    Contact: Principal Investigator (Widad Lahlou, MD)

  • Universitatsklinikum Franfurt, Frankfurt, Germany

    Study coordinator · marit.ahrens@unimedizin-ffm.de · 069 6301-5677
    Contact: Principal Investigator (Marit Ahrens, MD)

  • Universitätsklinikum Eppendorf, Hamburg, Germany

    Study coordinator · j.striefler@uke.de · 0152-22824370
    Contact: Principal Investigator (Jana Striefler, MD)

  • AOU Careggi - Padiglione 16 - Piano Terra - Ambulatori Oncologici - Ufficio Trial, Florence, Italy

    Study coordinator · lorenzo.antonuzzo@unifi.it · +39 0557947298
    Contact: Principal Investigator (Lorenzo Antonuzzo, MD)

  • IRCCS Azienda Ospedaliera Metropolitana, Genova, Italy

    Study coordinator · danila.comandini@aomliguria.it · 0105553301
    Contact: Principal Investigator (Danila Comandini, MD)

  • Istituto Europeo di Oncologia, Milan, Italy

    Study coordinator · Elisabetta.setola@ieo.it · +39 02 57489438
    Contact: Principal Investigator (Elisabetta Setola, MD)

  • Antonie Van Leeuwenhoek Hospital, Amsterdam, Netherlands

    Study coordinator · +31205122103
    Contact: Principal Investigator (Neeltje Steeghs, MD)

  • Radboudumc, Nijmegen, Netherlands

    Study coordinator · +31 (0)6 3113 6977
    Contact: Principal Investigator (Ingrid Desar, MD)

  • Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E., Porto, Portugal

    Study coordinator · antonio.m.abreu@ipoporto.min-saude.pt · +351 225084000
    Contact: Principal Investigator (Miguel Abreu, MD)

  • Hospital Universitario Ramón y Cajal, Madrid, Spain

    Study coordinator · mavaz4@gmail.com · +34 91 336 82 63 / 91 336 91 9
    Contact: Principal Investigator (Maria Angeles Vaz Salgado, MD)

  • Hospital Universitario Clinico San Carlos, Madrid, Spain

    Study coordinator · gloriamarquina@gmail.com · +34 91 330 30 00
    Contact: Principal Investigator (Gloria Marquina Ospina, MD)

  • Hospital Universitario Virgen Del Rocio, Seville, Spain

    Study coordinator · sanchomarquez@gmail.com · +34 955013068
    Contact: Principal Investigator (Maria Pilar Sancho Marquez, MD)

  • Inselspital Universitätsklinikum Bern, Bern, Switzerland

    Contact: Principal Investigator (Attila Kollar, MD)
Study leads

  • Clinical Team

    Study Director

    Deciphera Pharmaceuticals, LLC

View source on ClinicalTrials.gov(opens in a new tab)